EIF2B and oligodendrocyte survival: Where nature and nurture meet in bipolar disorder and schizophrenia?

Schizophrenia Bulletin

Volumn 33, Issue 6, 2007, Pages 1343-1353

  Carter, Christopher J ^a  

^a NONE   (United Kingdom)

Author keywords

Bipolar disorder; eIF2 alpha; eIF2B; Endoplasmic reticulum stress; Famine; Oligodendrocyte; Oxidative stress; Polygenic; Protein synthesis; Schizophrenia; Translation initiation; Virus

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOKINE; GENE PRODUCT; GLUTAMATE RECEPTOR; GROWTH FACTOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; PROTEIN KINASE R;

AKT1 GENE; ARTICLE; BIPOLAR DISORDER; CELL LOSS; CELL SURVIVAL; CELL TYPE; DAO GENE; DAOA GENE; DISC1 GENE; DISEASE PREDISPOSITION; DPYSL2 GENE; DTNB1 GENE; ENDOPLASMIC RETICULUM STRESS; ENVIRONMENTAL FACTOR; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; GENE; GENE LOCUS; GENE MUTATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GRIN1 GENE; GRIN2A GENE; GRIN2B GENE; GRM3 GENE; GRM4 GENE; HUMAN; HUNGER; IL1B GENE; IL1RN GENE; IMPA2 GENE; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MTHFR GENE; MULTIGENE FAMILY; NCAM1 GENE; ND4 GENE; NDUFV2 GENE; NERVE CELL PLASTICITY; NOS1 GENE; NOS1AP GENE; OLIGODENDROGLIA; OXIDATIVE STRESS; PDLIM5 GENE; PIK3C3 GENE; PIP5K2A GENE; PRENATAL STRESS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; RGS4 GENE; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; STARVATION; STRESS; TNF GENE; VIRUS INFECTION; WHITE MATTER; XBP1 GENE; YWHAH GENE;

APOPTOSIS REGULATORY PROTEINS; BIPOLAR DISORDER; ENVIRONMENTAL EXPOSURE; EUKARYOTIC INITIATION FACTOR-2B; GENOTYPE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; OLIGODENDROGLIA; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA;

EID: 35648967718     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbm007     Document Type: Article

References (97)

1. Murray RM, Jones PB, Susser E, Van Os J, Cannon M (eds). The Epidemiology of Schizophrenia. Cambridge: Cambridge University Press, 2002; 470, ISBN: 0-521-77540-X.
2. Brown AS, Van Os J, Driessens C, Hoek HW, Susser ES. Further evidence of relation between prenatal famine and major affective disorder. Am J Psychiatry. 2000;157:190-195.
3. Yolken RH, Torrey EF. Viruses, schizophrenia, and bipolar disorder. Clin Microbiol Rev. 1995;8:131-145.
4. Uranova N, Orlovskaya D, Vikhreva O, et al. Electron microscopy of oligodendroglia in severe mental illness. Brain Res Bull. 2001;55:597-610.
5. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI. Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res. 2004;67:269-275.
6. Chambers JS, Perrone-Bizzozero NI. Altered myelination of the hippocampal formation in subjects with schizophrenia and bipolar disorder. Neurochem Res. 2004;29:2293-2302.
7. McClellan JM, Susser E, King MC. Maternal famine, de novo mutations, and schizophrenia. JAMA. 2006;296:582-584.
8. Carter CJ. Schizophrenia susceptibility genes converge on interlinked pathways related to glutamatergic transmission and long-term potentiation, oxidative stress and oligodendrocyte viability. Schizophr Res. 2006;86:1-14.
9. Pronk JC, van Kollenburg B, Scheper GC, van der Knaap MS. Vanishing white matter disease: a review with focus on its genetics. Ment Retard Dev Disabil Res Rev. 2006;12:123-128.
10. Cullinan SB, Diehl JA. Coordination of ER and oxidative stress signaling: the PERK/Nrf2 signaling pathway. Int J Biochem Cell Biol. 2005;38:317-332.
11. Pavitt GD. eIF2B, a mediator of general and gene-specific translational control. Biochem Soc Trans. 2005;33:1487-1492.
12. Proud CG. Regulation of eukaryotic initiation factor eIF2B. Prog Mol Subcell Biol. 2001;26:95-114.
13. Wek RC, Jiang HY, Anthony TG. Coping with stress: eIF2 kinases and translational control. Biochem SocTrans. 2006;34:7-11.
14. Harding HP, Zhang Y, Zeng H, et al. An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol Cell. 2003;11:619-633.
15. Murphy P, Kolsto A. Expression of the bZIP transcription factor TCF11 and its potential dimerization partners during development. Mech Dev. 2000;97:141-148.
16. He CH, Gong P, Hu B, et al. Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. Implication for heme oxygenase-1 gene regulation. J Biol Chem. 2001;276:20858-20865.
17. Ma Y, Hendershot LM. Herp is dually regulated by both the endoplasmic reticulum stress-specific branch of the unfolded protein response and a branch that is shared with other cellular stress pathways. J Biol Chem. 2004;279:13792-13799.
18. Fawcett TW, Martindale JL, Guyton KZ, Hai T, Holbrook NJ. Complexes containing activating transcription factor (ATF)/cAMP-responsive-element-binding protein (CREB) interact with the CCAAT/enhancer-binding protein (C/EBP)-ATF composite site to regulate Gadd153 expression during the stress response. Biochem J. 1999;339:135-141.
19. Chan SL, Fu W, Zhang P, et al. Herp stabilizes neuronal Ca2+ homeostasis and mitochondrial function during endoplasmic reticulum stress. J Biol Chem. 2004;279:28733-28743.
20. Schulze A, Standera S, Buerger E, et al. The ubiquitin-domain protein HERP forms a complex with components of the endoplasmic reticulum associated degradation pathway. J Mol Biol. 2005;354:1021-1027.
21. Kaneko M, Nomura Y. ER signaling in unfolded protein response. Life Sci. 2003;74:199-205.
22. You KR, Liu MJ, Han XJ, Lee ZW, Kim DG. Transcriptional regulation of the human transferrin gene by GADD153 in hepatoma cells. Hepatology. 2003;38:745-755.
23. Maytin EV, Ubeda M, Lin JC, Habener JF. Stress-inducible transcription factor CHOP/gadd153 induces apoptosis in mammalian cells via p38 kinase-dependent and -independent mechanisms. Exp Cell Res. 2001;267:193-204.
24. Kandel ES, Hay N. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res. 1999;253:210-229.
25. Lafon-Cazal M, Perez V, Bockaert J, Marin P. Akt mediates the anti-apoptotic effect of NMDA but not that induced by potassium depolarization in cultured cerebellar granule cells. Eur J Neurosci. 2002;16:575-583.
26. Welsh GI, Miller CM, Loughlin AJ, Price NT, Proud CG. Regulation of eukaryotic initiation factor eIF2B: glycogen synthase kinase-3 phosphorylates a conserved serine which undergoes dephosphorylation in response to insulin. FEBS Lett. 1998;421:125-130.
27. Zhang K, Kaufman RJ. The unfolded protein response: a stress signaling pathway critical for health and disease. Neurology. 2006;66:S102-S109.
28. Lee AS. The ER chaperone and signaling regulator GRP78/BiP as a monitor of endoplasmic reticulum stress. Methods. 2005;35:373-381.
29. Lee AH, Iwakoshi NN, Glimcher LH. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol. 2003;23:7448-7459.
30. Roybal CN, Yang S, Sun CW, et al. Homocysteine increases the expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4. J Biol Chem. 2004;279:14844-14852.
31. Levine J, Sela BA, Osher Y, Belmaker RH. High homocysteine serum levels in young male schizophrenia and bipolar patients and in an animal model. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29:1181-1191.
32. Andreazza AC, Cassini C, Rosa AR, et al. Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res. 2006.
33. Cirelli C, Tononi G. Gene expression in the brain across the sleep-waking cycle. Brain Res. 2000;885:303-321.
34. Cirelli C, Gutierrez CM, Tononi G. Extensive and divergent effects of sleep and wakefulness on brain gene expression. Neuron. 2004;41:35-43.
35. Sanchez-Perez AM, Llansola M, Felipo V. Modulation of NMDA receptors by AKT kinase. Neurochem Int. 2006;49:351-358.
36. Wong R. NMDA receptors expressed in oligodendrocytes. Bioessays. 2006;28:460-464.
37. Jacques-Silva MC, Rodnight R, Lenz G, et al. P2X7 receptors stimulate AKT phosphorylation in astrocytes. Br J Pharmacol. 2004;141:1106-1117.
38. Back SA, Gan X, Li Y, Rosenberg PA, Volpe JJ. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J Neurosci. 1998;18:6241-6253.
39. Fujii H. Glucose-6-phosphate dehydrogenase. Nippon Rinsho. 1995;53:1221-1225.
40. Kirkpatrick B, Xu L, Cascella N, Ozeki Y, Sawa A, Roberts RC. DISC1 immunoreactivity at the light and ultrastructural level in the human neocortex. J Comp Neurol. 2006;497:436-450.
41. Millar JK, Christie S, Porteous DJ. Yeast two-hybrid screens implicate DISC1 in brain development and function. Biochem Biophys Res Commun. 2003;311:1019-1025.
42. Hafizi S, Ibraimi F, Dahlback B. C1-TEN is a negative regulator of the Akt/PKB signal transduction pathway and inhibits cell survival, proliferation, and migration. FASEB J. 2005;19:971-973.
43. Ozeki Y, Tomoda T, Kleiderlein J, et al. Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc Natl Acad Sci USA. 2003;100:289-294.
44. Husi H, Ward MA, Choudhary JS, Blackstock WP, Grant SG. Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat Neurosci. 2000;3:661-669.
45. Ogawa F, Kasai M, Akiyama T. A functional link between Disrupted-In-Schizophrenia 1 and the eukaryotic translation initiation factor 3. Biochem Biophys ResCommun. 2005;338:771-776.
46. Mayeur GL, Fraser CS, Peiretti F, Block KL, Hershey JW. Characterization of eIF3k: a newly discovered subunit of mammalian translation initiation factor elF3. Eur J Biochem. 2003;270:4133-4139.
47. Anderson P, Kedersha N. Visibly stressed: the role of eIF2, TIA-1, and stress granules in protein translation. Cell Stress Chaperones. 2002;7:213-221.
48. Wiggins RC, Fuller GN. Early postnatal starvation causes lasting brain hypomyelination. J Neurochem. 1978;30:1231-1237.
49. Kemper TL, Lecours AR, Gates MJ, Yakovlev PI. Retardation of the myelo- and cytoarchitectonic maturation of the brain in the congenital rubella syndrome. Res Publ Assoc Res Nerv Ment Dis. 1973;51:23-62.
50. Domegan LM, Atkins GJ. Apoptosis induction by the Therien and vaccine RA27/3 strains of rubella virus causes depletion of oligodendrocytes from rat neural cell cultures. J Gen Virol. 2002;83:2135-2143.
51. Kastrukoff LF, Lau AS, Kim SU. Multifocal CNS demyelination following peripheral inoculation with herpes simplex virus type 1. Ann Neurol. 1987;22:52-59.
52. Garcia-Monco JC, Fernandez Villar B, Szczepanski A, Benach JL. Cytotoxicity of Borrelia burgdorferi for cultured rat glial cells. J Infect Dis. 1991;163:1362-1366.
53. Blomgren K, Hagberg H. Free radicals, mitochondria, and hypoxia-ischemia in the developing brain. Free Radic Biol Med. 2006;40:388-397.
54. Do KQ, Trabesinger AH, Kirsten-Kruger M, et al. Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo. Eur J Neurosci. 2000;12:3721-3728.
55. van der Knaap MS, Pronk JC, Scheper GC. Vanishing white matter disease. Lancet Neurol. 2006;5:413-423.
56. Kantor L, Harding HP, Ron D, et al. Heightened stress response in primary fibroblasts expressing mutant eIF2B genes from CACH/VWM leukodystrophy patients. Hum Genet. 2005;118:99-106.
57. van Kollenburg B, Thomas AA, Vermeulen G, et al. Regulation of protein synthesis in lymphoblasts from vanishing white matter patients. Neurobiol Dis. 2006;21:496-504.
58. van Kollenburg B, van Dijk J, Garbern J, et al. Glia-specific activation of all pathways of the unfolded protein response in vanishing white matter disease. J Neuropathol Exp Neurol. 2006;65:707-715.
59. Stevens JR. Schizophrenia: reproductive hormones and the brain. Am J Psychiatry. 2002;159:713-719.
60. Sajatovic M, Rosenthal MB, Plax MS, Meyer ML, Bingham CR. Mental illness and menopause: a patient and family perspective. J Gend Specif Med. 2003;6:31-34.
61. Blehar MC, DePaulo JRJr, Gershon ES, Reich T, Simpson SG, Nurnberger JIJr. Women with bipolar disorder: findings from the NIMH Genetics Initiative sample. Psychopharmacol Bull. 1998;34:239-243.
62. Daban C, Vieta E, Mackin P, Young AH. Hypothalamicpituitary-adrenal axis and bipolar disorder. Psychiatr Clin North Am. 2005;28:469-480.
63. Caruso A, Di Giorgi Gerevini V, Castiglione M, et al. Testosterone amplifies excitotoxic damage of cultured oligodendrocytes. J Neurochem. 2004;88:1179-1185.
64. Takao T, Flint N, Lee L, Ying X, Merrill J, Chandross KJ. 17beta-estradiol protects oligodendrocytes from cytotoxicity induced cell death. J Neurochem. 2004;89:660-673.
65. Schumacher M, Guennoun R, Robert F, et al. Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination. Growth Horm IGF Res. 2004;14:Suppl AS18-S33.
66. Alonso G. Prolonged corticosterone treatment of adult rats inhibits the proliferation of oligodendrocyte progenitors present throughout white and gray matter regions of the brain. Glia. 2000;31:219-231.
67. Khorchid A, Fragoso G, Shore G, Almazan G. Catecholamine-induced oligodendrocyte cell death in culture is developmentally regulated and involves free radical generation and differential activation of caspase-3. Glia. 2002;40:283-299.
68. Noble PG, Antel JP, Yong VW. Astrocytes and catalase prevent the toxicity of catecholamines to oligodendrocytes. Brain Res. 1994;633:83-90.
69. Greenberg DB, Jonasch E, Gadd MA, et al. Adjuvant therapy of melanoma with interferon-alpha-2b is associated with mania and bipolar syndromes. Cancer. 2000;89:356-362.
70. Njenga MK, Coenen MJ, DeCuir N, Yeh HY, Rodriguez M. Short-term treatment with interferon-alpha/beta promotes remyelination, whereas long-term treatment aggravates demyelination in a murine model of multiple sclerosis. J Neurosci Res. 2000;59:661-670.
71. Popko B, Baerwald KD. Oligodendroglial response to the immune cytokine interferon gamma. Neurochem Res. 1999;24:331-338.
72. Cammer W. Protection of cultured oligodendrocytes against tumor necrosis factor-alpha by the antioxidants coenzyme Q(10) and N-acetyl cysteine. Brain Res Bull. 2002;58:587-592.
73. Takahashi JL, Giuliani F, Power C, Imai Y, Yong VW. Interleukin-1beta promotes oligodendrocyte death through glutamate excitotoxicity. Ann Neurol. 2003;53:588-595.
74. Pfeiffer BE, Huber KM. Current advances in local protein synthesis and synaptic plasticity. J Neurosci. 2006;26:7147-7150.
75. Pocklington AJ, Cumiskey M, Armstrong JD, Grant SG. The proteomes of neurotransmitter receptor complexes form modular networks with distributed functionality underlying plasticity and behaviour. Mol Syst Biol. 2006;2:2006.
76. Costa-Mattioli M, Gobert D, Stern E, et al. Translational control of synaptic plasticity and memory by the eIF2a signaling pathway. Soc Neurosci. 2006;632-16.
77. Hou S, Antoine M, Hoeffer C, et al. Translation initiation factor eIF2a phosphorylation during mGluR-LTD and L-LTP in hippocampal area CA1. Soc Neurosci. 2006;750-19.
78. Chen A, Muzzio IA, Malleret G, et al. Inducible enhancement of memory storage and synaptic plasticity in transgenic mice expressing an inhibitor of ATF4 (CREB-2) and C/EBP proteins. Neuron. 2003;39:655-669.
79. Costa-Mattioli M, Gobert D, Harding H, et al. Translational control of hippocampal synaptic plasticity and memory by the eIF2alpha kinase GCN2. Nature. 2005;436:1166-1173.
80. Higgs BW, Elashoff M, Richman S, Barci B. An online database for brain disease research. BMC Genomics. 2006;7:70.
81. McCurdy RD, Feron F, Perry C, et al. Cell cycle alterations in biopsied olfactory neuroepithelium in schizophrenia and bipolar I disorder using cell culture and gene expression analyses. Schizophr Res. 2006;82:163-173.
82. Moises HW, Schindler L, Leroux M, Kirchner H. Decreased production of interferon alpha and interferon gamma in leucocyte cultures of schizophrenic patients. Acta Psychiatr Scand. 1985;72:45-50.
83. Katila H, Cantell K, Hirvonen S, Rimon R. Production of interferon-alpha and gamma by leukocytes from patients with schizophrenia. Schizophr Res. 1989;2:361-365.
84. Gottesman I. Schizophrenia Genesis: The Origins of Madness. New York, NY: Freeman; 1991.
85. Craddock N, Jones I. Genetics of bipolar disorder. J Med Genet. 1999;36:585-594.
86. Blackwood DH, Fordyce A, Walker MT, St Clair DM, Porteous DJ, Muir WJ. Schizophrenia and affective disorders-cosegregation with a translocation at chromosome 1q42 that directly disrupts brain-expressed genes: clinical and P300 findings in a family. Am J Hum Genet. 2001;69:428-433.
87. Wu X, Gu J, Grossman HB, et al. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cyclecontrol genes. Am J Hum Genet. 2006;78:464-479.
88. Liu W, Breen G, Zhang J, et al. Association of APOE gene with schizophrenia in Chinese: a possible risk factor in times of malnutrition. Schizophr Res. 2003;62:225-230.
89. Dickerson FB, Boronow JJ, Stallings C, et al. The catechol O-methyltransferase Val158Met polymorphism and herpes simplex virus type 1 infection are risk factors for cognitive impairment in bipolar disorder: additive gene-environmental effects in a complex human psychiatric disorder. Bipolar Disord. 2006;8:124-132.
90. Paintlia MK, Paintlia AS, Barbosa E, Singh I, Singh AK. N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain. J Neurosci Res. 2004;78:347-361.
91. Zuckerman L, Weiner I. Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. J Psychiatr Res. 2005;39:311-323.
92. Ozawa K, Hashimoto K, Kishimoto T, Shimizu E, Ishikura H, Iyo M. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol Psychiatry. 2006;59:546-554.
93. Kaga Y, Shoemaker WJ, Furusho M, et al. Mice with conditional inactivation of fibroblast growth factor receptor-2 signaling in oligodendrocytes have normal myelin but display dramatic hyperactivity when combined with Cnp1 inactivation. J Neurosci. 2006;26:12339-12350.
94. Fields RD. Myelination: an overlooked mechanism of synaptic plasticity? Neuroscientist. 2005;11:528-531.
95. Hyde TM. Ziegler JC, Weinberger DR. Psychiatric disturbances in metachromatic leukodystrophy. Insights into the neurobiology of psychosis. Arch Neurol. 1992;49:401-406.
96. Feinstein A. The neuropsychiatry of multiple sclerosis. Can J Psychiatry. 2004;49:157-163.
97. Tsuang MT, Bar JL, Stone WS, Faraone SV. Gene-environment interactions in mental disorders. World Psychiatry. 2004;3:73-83.